Substantial progress in the treatment of atherosclerotic complications – in particular in secondary prevention – has led to a significant reduction of recurrent cardiovascular events. This has been through the use of pharmacological strategies including lipid-lowering drugs such as statins, beta-blockers, angiotensin-converting ensyme inhibitors and angiotensin receptor blockers, along with the introduction of early percutaneous coronary intervention in acute coronary syndrome with consecutive application of dual antiplatelet therapy.
Atherosclerosis
Atherosclerosis
About
Media
Watch time: 3m 25s
Watch time: 7m 44s
Watch time: 9m 40s
Articles
Fibrates — The Other Life-saving Lipid Drugs
Citation:
US Cardiology 2004;1(1):1–6
- Views:
499
- Downloads:
2
Developments in Magnetic Resonance Imaging of Atherosclerosis
Citation:
US Cardiology 2007;4(1):63–5
- Views:
409
- Downloads:
0
Upstream Treatments for Atrial Fibrillation
Citation:
US Cardiology 2007;4(1):20–2
- Views:
147
- Downloads:
0
Treating Atherogenic Dyslipidemia in Patients with Type 2 Diabetes—The Case for Using Fenofibrate
Citation:
US Cardiology 2005;2(1):39–43
- Views:
213
- Downloads:
0